Centers For Disease Control And Prevention
Clinical trials sponsored by Centers For Disease Control And Prevention, explained in plain language.
-
Boosted flu shot shows stronger immune response in hospital staff
⭐️ VACCINE ⭐️ CompletedThis study tested whether an enhanced flu vaccine (with an adjuvant) produces a stronger immune response than the standard flu shot in healthcare workers. About 192 hospital staff in Peru received either the adjuvanted or standard vaccine. Researchers measured antibody levels at …
Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 02:24 UTC
-
New rabies vaccine study shows promise for At-Risk adults
⭐️ VACCINE ⭐️ CompletedThis study tested a rabies vaccine given under the skin (intradermally) in 130 adults at risk of rabies exposure, such as lab workers and veterinarians. The goal was to see if the vaccine triggers a strong immune response and is safe. Results showed most participants developed pr…
Phase: NA • Sponsor: Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:03 UTC
-
New rotavirus vaccine passes first safety check in adults
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested an experimental inactivated rotavirus vaccine (CDC-9) in 50 healthy adults aged 18 to 45. The goal was to see if the vaccine is safe and whether it triggers an immune response. Participants received three shots, and researchers monitored for side eff…
Phase: PHASE1 • Sponsor: Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:07 UTC
-
Mpox vaccine trial for frontline workers shows promise in High-Risk region
⭐️ VACCINE ⭐️ CompletedThis study tested the JYNNEOS smallpox vaccine in 1,600 healthcare workers in the Democratic Republic of the Congo who are at high risk of catching mpox. The goal was to see if the vaccine can prevent mpox infection and is safe to use. Participants received the vaccine and were m…
Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:07 UTC
-
New TB prevention dosing study aims to protect children from active disease
Disease control CompletedThis study tested two medicines, rifapentine and isoniazid, to prevent active tuberculosis (TB) in children up to 12 years old who had latent (hidden) TB infection. The goal was to find the safest and most effective dose for both HIV-infected and HIV-uninfected children. Research…
Phase: PHASE1, PHASE2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated May 26, 2026 02:19 UTC
-
New hope against plague: common antibiotic tested in landmark trial
Disease control CompletedThis study tested whether the antibiotic ciprofloxacin works as well as doxycycline for treating plague, a serious bacterial infection spread by fleas. About 200 people in Uganda with suspected plague took either ciprofloxacin or doxycycline by mouth. The main goal was to see how…
Phase: PHASE2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Family flu fighter: simple steps to stop sickness at home!
Prevention CompletedThis study looked at whether using alcohol hand sanitizers and face masks can help stop colds and flu from spreading among family members. About 450 households in New York City with at least one young child took part. Families were split into three groups: one got educational mat…
Phase: NA • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated May 26, 2026 02:25 UTC
-
Can a music-and-movement program cut HIV risk in at-risk teens?
Prevention CompletedThis study tested a group program called PALMS (Preventing AIDS Through Live Movement and Sound) for African-American and Latino teen boys in juvenile justice or drug treatment centers. The goal was to see if it could reduce risky sexual behaviors and encourage HIV testing. The p…
Phase: PHASE1, PHASE2 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated May 26, 2026 02:20 UTC
-
Can a short video in the waiting room boost HIV treatment success?
Knowledge-focused CompletedThis study tested a brief video shown in HIV clinic waiting rooms. The goal was to help patients start antiretroviral therapy, stick with their medication, stay in care, and talk to their doctors about safer sex. Over 4,000 patients from clinics serving mostly African American an…
Phase: NA • Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated May 26, 2026 02:14 UTC
-
TB drug study aims to Fine-Tune treatment dosing
Knowledge-focused CompletedThis study looked at how two tuberculosis drugs, rifapentine and moxifloxacin, are processed in the body. Researchers took blood samples from 53 adults with TB to measure drug levels and see how they relate to treatment success and side effects. The goal is to improve dosing for …
Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC